What Is CYP2D6, and Why Does Terbinafine Block It?
CYP2D6 is a liver enzyme that clears many common medications from your body, and terbinafine is a well documented inhibitor of it. Picture CYP2D6 as a single lane road your liver uses to process certain drugs. Terbinafine parks itself across that lane, so other medications that rely on it back up in your bloodstream instead of clearing normally.
This matters because a number of everyday medications depend heavily on CYP2D6, including tricyclic antidepressants (TCAs) such as nortriptyline, imipramine, desipramine, and amitriptyline; several SSRIs; beta blockers; class 1C antiarrhythmics such as flecainide and propafenone; and monoamine oxidase type B inhibitors. This is the full list of CYP2D6 dependent drug classes named on terbinafine's FDA approved prescribing label, not just antidepressants. When terbinafine blocks the enzyme, these drugs can build up to higher than expected levels even though your prescribed dose hasn't changed.
What Does Terbinafine's FDA Label Actually Say About This Interaction?
Terbinafine's FDA approved prescribing label clearly states that it blocks a specific enzyme needed to process other medications. The label names five drug classes affected by this: tricyclic antidepressants, SSRIs, beta blockers, class 1C antiarrhythmics, and monoamine oxidase type B inhibitors. This isn't just a theory from outside researchers. It is a confirmed fact printed right on the government's official drug label.
The official drug label shows exactly what happens when these medications are mixed. In one study, giving terbinafine to someone already taking the antidepressant desipramine doubled the highest level of the antidepressant in their blood and increased their overall exposure by five times. Because of this massive spike, the label advises doctors to monitor patients closely and consider lowering their antidepressant dose if they need to take both drugs.
If your prescriber has flagged monitoring for you, our guide to blood tests for toenail fungus medication walks through what that actually involves.
What Do the Real Case Reports Actually Show?
Published medical reports describe cases where people developed drug toxicity, not mania, after taking terbinafine together with a tricyclic antidepressant (TCA).
Four separate reports published between 2001 and 2005 described a similar pattern. In each case, the person had been taking a TCA safely for months or even years. After starting terbinafine, they developed symptoms within 1 to 3 weeks, such as confusion, dizziness, difficulty keeping their balance, or a dry mouth. Blood tests showed that the level of the antidepressant in their body had become much higher than the normal range.
| Antidepressant | What happened | Source |
|---|---|---|
| Imipramine | Worsening mood and sleep, then a dizzy spell that caused a fall; blood level roughly double the patient's usual range | Teitelbaum and Pearson, 2001, American Journal of Psychiatry |
| Desipramine | Progressive dizziness advancing to difficulty walking and swallowing; blood level far above therapeutic range | O'Reardon et al., 2002, American Journal of Psychiatry |
| Nortriptyline | Drug toxicity confirmed by testing; occurred in a patient without any CYP2D6 genetic risk variant, showing the interaction isn't limited to people with unusual genetics | van der Kuy et al., 2002, Annals of Pharmacotherapy |
| Amitriptyline and nortriptyline | Dry mouth, nausea, and dizziness with elevated combined blood levels that took about six months to return to baseline | Castberg et al., 2005, Therapeutic Drug Monitoring |
Does Terbinafine Really Cause Mania?
The concern that terbinafine can trigger mania is based on one published case. It involved a 66-year-old woman taking venlafaxine and mirtazapine, two antidepressants that work differently from the more familiar SSRIs and tricyclic antidepressants. These medicines rely less on the CYP2D6 enzyme to break down than tricyclic antidepressants do.
She developed agitation consistent with a manic episode about two months after starting terbinafine, and the authors, reasonably, suspected the same enzyme blocking mechanism was involved. That's a fair observation, but it was published only as a short conference abstract in European Psychiatry, roughly two paragraphs long, never as a full case report with detailed labs and follow up. No fuller version has since been published.
How Long Does the Interaction Risk Last After You Stop Terbinafine?
Terbinafine's effect on CYP2D6 can linger for weeks to months after your last dose, because the drug settles into fat and skin tissue and slowly releases back into your bloodstream. The FDA label's own study still showed elevated antidepressant levels four weeks after stopping terbinafine, which was simply the last point researchers measured, not necessarily when the effect actually ended.
This is one of the clearest reasons oral and topical approaches differ so much in practice. You can read more in our complete guide to oral antifungals, their risks, and alternatives.
What Should You Do If You're Prescribed Terbinafine While on an Antidepressant?
Start by disclosing every medication you take before you begin terbinafine, then stay alert for the length of treatment and beyond. Specifically:
- Tell your prescriber and pharmacist about every antidepressant, beta blocker, antiarrhythmic, or monoamine oxidase inhibitor you take before starting terbinafine, not just the ones that feel relevant.
- Ask whether your dose should be monitored more closely while you're taking both medications, and confirm the plan for baseline and follow up liver function testing, which terbinafine requires regardless of what else you take.
- Watch for new or worsening confusion, dizziness, unsteadiness, dry mouth, or mood changes during treatment.
- Keep watching for months after you stop terbinafine, since the interaction can outlast the prescription itself.
If you're still weighing how to approach the infection itself, our guide to recognizing toenail fungus symptoms early is a good place to start.
Frequently Asked Questions About Terbinafine and Antidepressants
Can terbinafine cause mania in people taking SSRIs?
There's no published case report of terbinafine causing mania in someone on a classic SSRI. The one documented mania case involved venlafaxine and mirtazapine, two different antidepressant classes, and was published only as a brief conference abstract. Source.
Is it safe to take terbinafine with antidepressants?
It can be done, but it requires disclosure and monitoring. Terbinafine's FDA label recommends careful monitoring when combined with tricyclic antidepressants, SSRIs, beta blockers, class 1C antiarrhythmics, or monoamine oxidase type B inhibitors, since it can raise their blood levels. Separately, everyone on oral terbinafine needs baseline liver function testing, whether or not they take an antidepressant. Source.
How does terbinafine interact with antidepressants?
Terbinafine blocks a liver enzyme called CYP2D6, which many antidepressants and several other drug classes rely on to clear from your body. When it's blocked, those medications can build up to higher than expected levels even at an unchanged dose. With paroxetine and fluoxetine specifically, the interaction is compounded because those SSRIs are also CYP2D6 inhibitors in their own right.
How long does the terbinafine antidepressant interaction last after stopping?
Published data shows elevated antidepressant levels persisting at least four weeks after stopping terbinafine, and one case took about six months to fully normalize, since terbinafine slowly releases from fat and skin tissue. Source.
Which antidepressants carry the highest risk with terbinafine?
Tricyclic antidepressants, such as nortriptyline, imipramine, desipramine, and amitriptyline, carry the best documented risk, with multiple published toxicity case reports. Among SSRIs, paroxetine and fluoxetine carry a distinct added risk because they inhibit CYP2D6 themselves.
Why does my doctor order blood tests during terbinafine treatment?
Mostly for liver monitoring. Oral terbinafine carries a hepatotoxicity risk on its own, unrelated to the antidepressant interaction, and the FDA recommends baseline liver function tests for every patient plus periodic monitoring during treatment. If you also take a CYP2D6 dependent medication, your prescriber may add antidepressant level checks on top of that. Source.
Key Takeaways
- Terbinafine is an FDA documented CYP2D6 inhibitor that can raise the blood levels of tricyclic antidepressants, SSRIs, beta blockers, class 1C antiarrhythmics, and monoamine oxidase type B inhibitors, not just antidepressants.
- The clearest documented risk is tricyclic antidepressant toxicity, shown across four published case reports between 2001 and 2005.
- Paroxetine and fluoxetine carry an added layer of risk because they inhibit CYP2D6 themselves, on top of terbinafine's effect.
- The single mania case involved venlafaxine and mirtazapine, not a classic SSRI or TCA, and was only a brief conference abstract.
- No SSRI specific mania case report exists in the published medical literature, though that reflects a lack of reports rather than proof of zero risk.
- The interaction can persist for weeks to months after you stop taking terbinafine.
- Baseline and periodic liver function testing is recommended for everyone on oral terbinafine, for reasons separate from the antidepressant interaction.
- Tell your prescriber and pharmacist about every antidepressant before starting terbinafine, and keep watching for new symptoms during and after treatment.
Comments